S-OA-I Oral Abstracts - Session I - GVH/GVL & Hematopoiesis/Mesenchymal Cells

Track: BMT Tandem "Scientific" Meeting
Friday, February 15, 2013: 10:30 AM-12:00 PM
Ballroom E-H (Salt Palace Convention Center)
Chairs:
Alan M. Hanash, MD, PhD and Sophie Paczesny
Summary:

Abstracts: #2186, 2241, 2401, 2600, 2058, 2662

58
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Olle Ringden, MD, PhD, Karolinska. Institutet; Tom Erkers, MSc, Karolinska Institutet; Silvia Nava, BSc, Karolinska Institutet; Mehmet Uzunel, MD, PhD, Karolinska University Hospital; Erik Iwarsson, MD, Karolinska Institutet; Réka Conrad, PhD, Karolinska Institutet; Magnus Westgren, MD, PhD, Karolinska Institutet; Jonas Mattsson, MD PhD, Karolinska University Hospital; Helen Kaipe, PhD, Karolinska Institutet

59
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Hidetaka Uryu, Kyushu University Graduate School of Medical Science; Hideyo Oka, Kyushu University Graduate School of Medical Science; Sonoko Shimoji, Kyushu University Graduate School of Medical Science; Yoshihiro Eriguchi, Kyushu University Graduate School of Medical Science; Shuichiro Takashima, Kyushu University Graduate School of Medical Science; Koji Kato, Kyushu University Graduate School of Medical Science; Koichi Akashi, Kyushu University Graduate School of Medical Science; Takanori Teshima, Hokkaido University Graduate School of Medicine

60
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Mark Vander Lugt, MD, University of Michigan; Thomas Braun, Ph.D., University of Michigan; Samir Hanash, MD, PhD, Fred Hutchinson Cancer Research Center; James L.M. Ferrara, M.D., D.Sc., University of Michigan; Jerome Ritz, MD, Dana-Farber Cancer Institute; Vincent T. Ho, MD, Dana-Farber Cancer Institute; Joseph H Antin, MD, Dana-Farber Cancer Institute; Qing Zhang, Fred Hutchinson Cancer Research Center; Alice Chin, Fred Hutchinson Cancer Research Center; Aurelie Gomez, MD, University of Michigan; Andrew C. Harris, M.D., University of Michigan; John E Levine, M.D., M.S., University of Michigan; Sung Won Choi, M.D., University of Michigan; Daniel R. Couriel, M.D., University of Michigan; Pavan Reddy, M.D., University of Michigan; Sophie Paczesny, M.D., Ph.D., University of Michigan

61
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Kirsten M Williams, MD, Children's National Medical Center; Steven Z. Pavletic, MD, National Institute of Health NIH; Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center; Candice Cottle-Delisle, RN, ETIB/NCI/NIH; Fran Hakim, PhD, National Cancer Institute, Nih; Beryl Manning-Geiss, NCI/NIH; Sandra Mitchell, PhD, CRNP, National Institutes of Health; Juan Gea-Banacloche, MD, National Institute of Health NIH; Leora Comis, NIH; Edward W Cowen, MD, NIH; Kristin Baird, MD, National Institute of Health NIH; James H Shelhamer, MD, CCMD NIH; Daniel Fowler, MD, National Institute of Health; Bazetta AJ Blacklock-Schuver, RN, ETIB/NCI/NIH; Daniele Avila, MSN, NCI; Ronald Gress, MD, National Cancer Institute

62
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Albert C Yeh, BA, Harvard Medical School; Andrew M. Brunner, MD, Massachusetts General Hospital; Thomas R. Spitzer, MD, Massachusetts General Hospital; Yi-Bin Chen, MD, Massachusetts General Hospital; Erin Coughlin, Massachusetts General Hospital; Steven L. McAfee, MD, Massachusetts General Hospital; Karen Ballen, MD, Massachusetts General Hospital; Eyal C. Attar, MD, Massachusetts General Hospital; Martin L Caron, Massachusetts General Hospital; Frederick Preffer, PhD, Massachusetts General Hospital; Beow Yeap, ScD, Massachusetts General Hospital; Bimalangshu R Dey, MD, PhD, Massachusetts General Hospital

63
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Liane te Boome, MD, UMC Utrecht; Cristina Mansilla, BsC, PhD, Biomedical Research Center of Navarra; Caroline Lindemans, MD, PhD, UMC Utrecht, Wilhelmina Children's Hospital; Lotte van der Wagen, MD, UMC Utrecht; Marloes Cuijpers, MD, UMC Utrecht; Ineke Slaper-Cortenbach, PhD, UMC Utrecht; Henk Rozemuller, PhD, UMC Utrecht; Eefke Petersen, MD, PhD, UMC Utrecht; Eric Spierings, PhD, UMC Utrecht; Marc Bierings, MD, University Children's Hospital; Jaap-Jan Boelens, MD, PhD, Wilhelmina Children's Hospital/UMCU; Nico Wullfraat, MD, PhD, UMC Utrecht; Jurgen Kuball, Associate Professor, UMC Utrecht